Back to the main directory
Press Release
- Prudential Global Short Duration High Yield Fund, Inc. Reports Unaudited Earnings and Financial Position for Quarter Ended July 31, 2017 by BusinessWire
- Eagle Growth and Income Opportunities Fund Declares Monthly Distribution of $0.083 Per Share and Announces Investor Call by BusinessWire
- ZTO EXPRESS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing in ZTO Express (Cayman) Inc. to Contact the Firm by BusinessWire
- BLUE APRON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Blue Apron Holdings, Inc. To Contact The Firm by BusinessWire
- Cigna Named to Dow Jones Sustainability Indices; Takes Top Spot in Its Sector by BusinessWire
- Bragar Eagel & Squire, P.C. is Investigating Equifax Inc. (EFX) on Behalf of Stockholders and Encourages Investors to Contact the Firm by BusinessWire
- DexCom Announces Upcoming Conference Presentation by BusinessWire
- United Rentals Announces Pricing of Offering of $750 Million of Senior Notes Due 2025 and $750 Million of Senior Notes Due 2028 by BusinessWire
- EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Endo International plc – ENDP by BusinessWire
- AstraZeneca’s TAGRISSO® (osimertinib) Shows Potential as a New Standard of Care in 1st-Line EGFR-Mutated Non-Small Cell Lung Cancer at ESMO 2017 Congress by BusinessWire
- Ellington Financial LLC Reports Estimated Book Value Per Share as of August 31, 2017 by BusinessWire
- TEVA LOSS NOTICE: Rosen Law Firm Reminds Teva Pharmaceutical Industries Ltd. Investors of Important Deadline in Class Action – TEVA by BusinessWire
- TOPS LOSS NOTICE: Rosen Law Firm Reminds Top Ships Inc. Investors of Important Deadline in Class Action – TOPS by BusinessWire
- KBW Announces Index Rebalancing for Third-Quarter 2017 by BusinessWire
- ELECTRONICS FOR IMAGING SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Electronics for Imaging, Inc. - (EFII) by BusinessWire
- HD SUPPLY 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against HD Supply Holdings, Inc. - (HDS) by BusinessWire
- ZEBRA TECHNOLOGIES SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Zebra Technologies Corporation - (ZBRA) by BusinessWire
- BLUE APRON SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Blue Apron Holdings, Inc. - (APRN) by BusinessWire
- EQUIFAX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Equifax Inc. for Possible Securities Fraud - (EFX) by BusinessWire
- SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Dr. Reddy’s Laboratories Ltd. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit by BusinessWire
- SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Vitamin Shoppe, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit by BusinessWire
- Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine by BusinessWire
- Progression-Free Survival Data from ECHO-202 Trial of Incyte’s Epacadostat in Combination with KEYTRUDA® (pembrolizumab) Underscore Durability of Response in Patients with Advanced Melanoma by BusinessWire
- Intersect ENT Announces Presentation of a Meta-Analysis From Two Randomized Studies Evaluating the Safety and Efficacy of SINUVAâ„¢, an Investigational Steroid Releasing Sinus Implant by BusinessWire
- Exelixis and Ipsen Announce Results from Phase 2 CABOSUN Trial of Cabozantinib versus Sunitinib in Previously Untreated Advanced Renal Cell Carcinoma at ESMO 2017 by BusinessWire
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of First South Bancorp, Inc. to Carolina Financial Corporation Is Fair to Shareholders by BusinessWire
- Boston Properties to Participate in the Barclays Global Financial Services Conference by BusinessWire
- THL Credit Senior Loan Fund Declares Monthly Distribution of $0.096 Per Share and Announces Investor Call by BusinessWire
- Certain Deutsche Closed-End Funds Declare Monthly Distributions by BusinessWire
- Frontier Communications Work Schedules, Service Order Impacts from Hurricane Irma by BusinessWire
- Aimco Declares Dividend on Class A Cumulative Preferred Stock by BusinessWire
- Exelon Utilities Mobilize Crews to Assist with Restoring Power to Customers in the Path of Hurricane Irma by BusinessWire
- Walgreens Reminds Patients About Prescription Preparedness in Advance of Hurricane Irma by BusinessWire
- AstraZeneca Presents Superior Progression-Free Survival for IMFINZI® (durvalumab) in the Pacific Trial of Patients with Locally-Advanced Unresectable Lung Cancer at ESMO 2017 Congress by BusinessWire
- Wells Fargo Mobilizes to Help Customers Impacted by Hurricane Harvey by BusinessWire
- PETS LOSS NOTICE: Rosen Law Firm Reminds PetMed Express, Inc. Investors of Important Deadline in Class Action – PETS by BusinessWire
- VSI LOSS NOTICE: Rosen Law Firm Reminds Vitamin Shoppe, Inc. Investors of Important Deadline in Class Action – VSI by BusinessWire
- Agellan Commercial Real Estate Investment Trust Provides Update on Impact of Tropical Storm Harvey and Announces Lease Amendments with an Existing Tenant by BusinessWire
- ARCONIC 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Arconic, Inc. - (ARNC, ARNC-P, ARNC-PB) by BusinessWire
- ADVISORY BOARD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against The Advisory Board Company - (ABCO) by BusinessWire
- MAXIMUS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against MAXIMUS, Inc. - (MMS) by BusinessWire
- FOUNDATION MEDICINE SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Foundation Medicine, Inc. - (FMI) by BusinessWire
- TINTRI INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Tintri, Inc. for Possible Securities Fraud - TNTR by BusinessWire
- SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Zillow Group, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit by BusinessWire
- SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Top Ships Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit by BusinessWire
- Baker Hughes, a GE Company Awarded Subsea Contract by Petrobel for Phase 2 Development of Egypt’s ‘Super Giant’ Zohr Gas Field by BusinessWire
- Progression-Free Survival Data from ECHO-202 Trial of Incyte’s Epacadostat in Combination with Merck’s KEYTRUDA® (pembrolizumab) Underscore Durability of Response in Patients with Advanced Melanoma by BusinessWire
- Frontier Communications Work Schedules, Service Order Impacts from Hurricane Irma in the Tampa Bay Area by BusinessWire
- Les données de survie sans progression de l'essai ECHO-202 sur l'épacadostat d'Incyte en combinaison avec le KEYTRUDA® (pembrolizumab) mettent en avant la durabilité de la réponse chez les patients atteints de mélanome avancé by BusinessWire
- Ipsen and Exelixis Announce Results from Phase 2 CABOSUN Trial of Cabozantinib versus Sunitinib in Previously Untreated Advanced Renal Cell Carcinoma at ESMO 2017 by BusinessWire